HK120497A - Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases - Google Patents

Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases Download PDF

Info

Publication number
HK120497A
HK120497A HK120497A HK120497A HK120497A HK 120497 A HK120497 A HK 120497A HK 120497 A HK120497 A HK 120497A HK 120497 A HK120497 A HK 120497A HK 120497 A HK120497 A HK 120497A
Authority
HK
Hong Kong
Prior art keywords
alcohols
inflammatory
treatment
aliphatic alcohols
triacontanol
Prior art date
Application number
HK120497A
Other languages
English (en)
French (fr)
Inventor
David H. Katz
Original Assignee
Lidak Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lidak Pharmaceuticals filed Critical Lidak Pharmaceuticals
Publication of HK120497A publication Critical patent/HK120497A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Claims (1)

  1. Verwendung einer Zusammensetzung von Materie bestehend im wesentlichen aus Docosanol, Tetracosanol oder Hexacosanol oder Mischungen davon zur Herstellung eines Medikaments für die Behandlung viraler Erkrankungen oder entzündlicher Erkrankungen bei Menschen oder Tieren.
HK120497A 1989-04-28 1997-06-26 Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases HK120497A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/345,084 US4874794A (en) 1989-04-28 1989-04-28 Inflammatory disease treatment
PCT/US1990/002045 WO1990013216A2 (en) 1989-04-28 1990-04-16 Inflammatory disease treatment

Publications (1)

Publication Number Publication Date
HK120497A true HK120497A (en) 1997-09-05

Family

ID=23353439

Family Applications (1)

Application Number Title Priority Date Filing Date
HK120497A HK120497A (en) 1989-04-28 1997-06-26 Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases

Country Status (10)

Country Link
US (1) US4874794A (de)
EP (1) EP0428642B1 (de)
JP (1) JPH03505882A (de)
AT (1) ATE95060T1 (de)
DE (2) DE69003652T2 (de)
DK (1) DK0428642T3 (de)
ES (1) ES2060158T3 (de)
HK (1) HK120497A (de)
NL (1) NL300354I2 (de)
WO (1) WO1990013216A2 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury
WO1991005754A2 (fr) * 1989-10-13 1991-05-02 Medafor Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
US5296514A (en) * 1991-04-23 1994-03-22 Summit Technology, Inc. Corneal treatment agents
US5214071A (en) * 1991-04-23 1993-05-25 Summit Technology, Inc. Corneal treatment agents
US5098896A (en) * 1991-04-23 1992-03-24 Summit Technology, Inc. Corneal treatment agents
US5198217A (en) * 1991-09-24 1993-03-30 Choice Pharmaceuticals Topical demulcent for viral and inflammatory diseases of the skin
SG43833A1 (en) * 1993-12-13 1997-11-14 Lidak Pharmaceuticals Sucrose ester-c20 to c25 alcohol formulations
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
DE60020914T2 (de) 1999-09-03 2005-12-01 Cabby Business Inc., Road Town Effizientes Verfahren zur Herstellung sehr reiner Sterinen
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
DE60122304T2 (de) * 2000-04-12 2007-08-09 Liplasome Pharma A/S Auf lipiden basierendes system zur zielgerichteten verabreichung diagnostischer wirkstoffe
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
HRP20040421B1 (hr) * 2001-10-16 2013-05-31 Avanir Pharmaceuticals INHIBICIJA VIRUSA n-DOKOZANOLOM
DE10203688A1 (de) 2002-01-31 2003-08-07 Bayer Cropscience Ag Synergistische insektizide Mischungen
DE10207242A1 (de) * 2002-02-21 2003-09-04 Bayer Cropscience Ag Synergistische insektizide Mischungen
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP2977043A3 (de) 2003-08-25 2016-04-06 Foamix Pharmaceuticals Ltd. Eindringender pharmazeutischer schaum
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (de) 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
WO2011112997A1 (en) 2010-03-11 2011-09-15 Chemic Laboratories, Inc. Novel compositions and methods
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
WO2017029647A1 (en) 2015-08-20 2017-02-23 Meir Eini Tetracycline management of egfr inhibitor associated dermatoses
US11185487B2 (en) 2015-12-28 2021-11-30 Johnson & Johnson Consumer Inc. Hair growth composition and method
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
EP4003302A1 (de) 2019-07-31 2022-06-01 Journey Medical Corporation Zusammensetzungen und verfahren und verwendungen davon
IL294239A (en) 2019-12-31 2022-08-01 Vyne Therapeutics Inc Topical composition comprising tofacitinib and fingolimod

Also Published As

Publication number Publication date
ATE95060T1 (de) 1993-10-15
JPH03505882A (ja) 1991-12-19
NL300354I2 (nl) 2008-10-01
DE122007000080I2 (de) 2008-11-06
ES2060158T3 (es) 1994-11-16
EP0428642B1 (de) 1993-09-29
DE69003652T2 (de) 1994-03-24
NL300354I1 (nl) 2008-08-01
DE122007000080I1 (de) 2008-02-28
DE69003652D1 (de) 1993-11-04
WO1990013216A2 (en) 1990-11-15
US4874794A (en) 1989-10-17
DK0428642T3 (da) 1994-02-21
EP0428642A1 (de) 1991-05-29

Similar Documents

Publication Publication Date Title
EP0428642B1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen
US7371396B2 (en) Dermatological and cosmetic compositions
US5104655A (en) Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
US5057501A (en) Methods for treatment of papulosquamous and eczematous diseases
KR100775803B1 (ko) 유효 성분으로서 보효소 ｑ 를 함유하는 피부용 조성물
US20030170194A1 (en) Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid
EP0171084A2 (de) Pharmazeutische Mikroemulsionen des Öl-in-Wasser-Typs
US5219880A (en) Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
US5166219A (en) Systemic anti-inflammatory treatment
US5194451A (en) Systemic anti-inflammatory treatment
EP0022046A1 (de) Arzneimittelzusammensetzung auf Pflanzenbasis und Verfahren zur Herstellung
DE69724629T2 (de) Zusammensetzungen und deren verwendungen
EP0469064B1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen
BRPI0715157A2 (pt) mÉtodo de tratamento e composiÇço antiviral tàpica
US5070107A (en) Systemic antiviral treatment
WO2013040721A1 (es) Proceso y sistema para la fabricación de acietes naturales ozonizados y su aplicación el tratamiento en humanos, animales, vegetales y en acuicultura
US4983625A (en) Psoralene-based bath compositions for treatment of skin disorders
RU2233152C1 (ru) Крем противовоспалительного и противозудного действия для лечения дерматологических заболеваний
RU2475230C1 (ru) Лечебно-косметическое средство для защиты кожи от солнечных ожогов
PT98757A (pt) Processo para a preparacao de uma composicao farmaceutica para o tratamento da psoriase contendo acido gama-linolico como ingrediente activo
DE68902792T2 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
JP2506388B2 (ja) 皮膚外用剤
IT202300025656A1 (it) Formulazione auto-emulsionante per uso topico
RU92014370A (ru) Препарат для лечения тяжелых кожных заболеваний на основе 13-цис-ретиноевой кислоты

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100415